Jansson, Fanny J.
,
Forsblom, Carol
Harjutsalo, Valma
Thorn, Lena M.
Wadén, Johan
Elonen, Nina
Ahola, Aila J.
Saraheimo, Markku
Groop, Per-Henrik
Article History
Received: 30 October 2017
Accepted: 3 January 2018
First Online: 8 February 2018
Duality of interest
: MS is an advisory board member for Medtronic in Scandinavia and has received lecture fees from Eli Lilly, Medtronic Finland, MSD, Novartis, Novo Nordisk, Roche and Sanofi. P-HG has received research grants from Eli Lilly and Roche; is an advisory board member for AbbVie, AstraZeneca, Boehringer Ingelheim, Cebix, Eli Lilly, Jansen, MSD, Novartis, NovoNordisk and Sanofi; and has received lecture fees from Boehringer Ingelheim, Eli Lilly, Elo Water, Genzyme, MSD, Novartis, Novo Nordisk and Sanofi. No other potential conflicts of interest relevant to this article were reported.